{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:13:58Z","timestamp":1774988038481,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T00:00:00Z","timestamp":1509753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bjid.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T22:30:15Z","timestamp":1510612215000},"page":"11-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections"],"prefix":"10.1016","volume":"22","author":[{"given":"Let\u00edcia Aparecida","family":"Schiave","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Crivelenti","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tissiana Marques","family":"de Haes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo Massaiti","family":"Takayanagui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane Masetto de","family":"Gaitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2017.10.003_bib0140","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2165\/11596540-000000000-00000","article-title":"Triazole antifungal agents in invasive fungal infections: a comparative review","volume":"71","author":"Lass-Fl\u00f6rl","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.bjid.2017.10.003_bib0145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV \u2013 associated cryptococcal meningitis after initial fluconazole monotherapy. The role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.003_bib0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.003_bib0155","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV \u2013 associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.003_bib0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1590\/S1413-86702007000200006","article-title":"Efficacy of amphotericin B in a fat emulsion for the treatment of cryptococcal meningitis in AIDS patients","volume":"11","author":"Rubio","year":"2007","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.003_bib0165","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4269\/ajtmh.15-0595","article-title":"Refractory and\/or relapsing cryptococcosis associated with AIDS: clinical features, genotype and virulence factors of Cryptococcus spp. isolates","volume":"94","author":"Nascimento","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bjid.2017.10.003_bib0170","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw076","article-title":"Retrospective study of cryptococcal meningitis with elevated minimum inibitory concentration to fluconazole in immunocompromised patients","volume":"3","author":"Nasri","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.003_bib0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.32.3.369","article-title":"Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis","volume":"32","author":"Tucker","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.003_bib0180","doi-asserted-by":"crossref","first-page":"e0141872","DOI":"10.1371\/journal.pone.0141872","article-title":"Demonstration of therapeutic equivalence of fluconazole generic products in the neutropenic mouse model of disseminated candidiasis","volume":"10","author":"Gonzalez","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bjid.2017.10.003_bib0185","first-page":"765","article-title":"Monitoring of fluconazole in serum of patients undergoing hemodiafiltration by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection","volume":"67","author":"Misoguchi","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.bjid.2017.10.003_bib0190","series-title":"M27-A2. Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute (CLSI).","year":"2008"},{"key":"10.1016\/j.bjid.2017.10.003_bib0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/AAC.00474-06","article-title":"Association of fluconazole area under the concentration time curve\/MIC and dose\/MIC ratios with mortality in nonneutropenic patients with candidemia","volume":"51","author":"Pai","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.003_bib0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13054-015-0758-3","article-title":"Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients study","volume":"19","author":"Sinnollaredy","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2017.10.003_bib0205","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1128\/AAC.00296-07","article-title":"Correlation of the MIC and dose\/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia","author":"Rodr\u00edguez-Tudela","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.003_bib0210","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.00216-13","article-title":"Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints","volume":"57","author":"Sudan","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.003_bib0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2016.05.022","article-title":"Pharmacokinetics\/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis","volume":"92","author":"Santos","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bjid.2017.10.003_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s001340000771","article-title":"Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function","volume":"27","author":"Buijk","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2017.10.003_bib0225","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2125.2004.02073.x","article-title":"Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers","volume":"57","author":"Sobue","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bjid.2017.10.003_bib0230","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1468-1293.2009.00778.x","article-title":"Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV associated cryptococcal meningitis infected patients","volume":"11","author":"Manosuthi","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.bjid.2017.10.003_bib0235","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/clinids\/22.5.838","article-title":"High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS","volume":"22","author":"Menichetti","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.003_bib0240","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/mmy\/myw031","article-title":"Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: trough serum concentrations in relation to outcome","volume":"54","author":"Ceesay","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.bjid.2017.10.003_bib0245","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood\u2013brain barrier for treatment of central nervous infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bjid.2017.10.003_bib0250","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","article-title":"Cryptococcus neoformans \u2013 Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cut off values for fluconazole, itraconazole, posaconazole, and voriconazole","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob Ag Chemother"},{"key":"10.1016\/j.bjid.2017.10.003_bib0255","doi-asserted-by":"crossref","DOI":"10.1007\/s11046-017-0165-1","article-title":"Fluconazole non-susceptible Cryptococcus neoformans, relapsing\/refractory cryptococcosis and long-term use of liposomal amphotericin B in an AIDS patient","author":"de Carvalho Santana","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2017.10.003_bib0260","first-page":"5","article-title":"Plasma pharmacokinetics of antimicrobial agents in critically ill patients","volume":"8","author":"Pea","year":"2013","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.bjid.2017.10.003_bib0265","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10156-012-0368-9","article-title":"Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis","volume":"18","author":"Shoji","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bjid.2017.10.003_bib0270","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/17425255.2014.883379","article-title":"Clinically relevant drug-drug interactions between antiretrovirals and antifungals","volume":"10","author":"Vadlapatla","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017306517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017306517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T02:58:01Z","timestamp":1535252281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867017306517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1413867017306517"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2017.10.003","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}